July/August 2020
Biopharma Asia
July/August 2020 | Volume 9 Issue 4
The Next Frontier in Subvisible Particle Analysis: New Tools and Opportunities
Danny Chou, President and Founder, Compassion BioSolution, LLC
COVID-19 Pandemic in the Context of Historical Pandemics – Probable Causes for Devastati...
Rajesh K. Gupta, President and Principal Consultant, Biologics Quality & Regulatory Co...
Considerations in the Technology Transfer and Scale up of Lyophilised Products
Tim McCoy, Principal Scientist, Matthew Brown, Development Scientist, Martin Addo, Seni...
Phase III/Post-Commercialisation Changes: Extractable and Leachables Considerations for Co...
Ken Wong, Deputy Director, Sanofi Pasteur
Addressing Material Properties in the Design of a Direct Compression Continuous Manufactur...
Fernando Muzzio, Professor, Sarang Oka, Graduate, William Engisch, Graduate, Rutgers Un...
Flexible Platform Solutions Overcome Vaccine Production Challenges
Pall Biotech
















